Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 May;34(5):1238-44.
doi: 10.2337/dc11-0079.

Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies

Caroline K Kramer  1 , Ticiana C Rodrigues, Luis H Canani, Jorge L Gross, Mirela J Azevedo
Affiliations
Meta-Analysis

Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies

Caroline K Kramer et al. Diabetes Care. 2011 May.

Abstract

Objective: The prognostic significance of diabetic retinopathy (DR) for death and cardiovascular (CV) outcomes is debated. We investigated the association of DR with all-cause mortality and CV events in patients with diabetes by a systematic review and meta-analysis.

Research design and methods: The electronic databases Medline and Embase were searched for cohort studies that evaluated DR in type 2 or type 1 diabetic patients and reported total mortality and/or fatal and nonfatal CV events, including myocardial infarction, angina pectoris, coronary artery bypass graft, ischemic changes on a conventional 12-lead electrocardiogram, transient ischemic attack, nonfatal stroke, or lower leg amputation. Data extraction was performed by two reviewers independently. Pooled effect estimates were obtained by using random-effects meta-analysis.

Results: The analysis included 20 studies that fulfilled the inclusion criteria, providing data from 19,234 patients. In patients with type 2 diabetes (n = 14,896), the presence of any degree of DR increased the chance for all-cause mortality and/or CV events by 2.34 (95% CI 1.96-2.80) compared with patients without DR. In patients with type 1 diabetes (n = 4,438), the corresponding odds ratio was 4.10 (1.50-11.18). These associations remained after adjusting for traditional CV risk factors. DR was also predictive of all-cause mortality in type 2 diabetes (odds ratio 2.41 [1.87-3.10]) and type 1 diabetes (3.65 [1.05-12.66]).

Conclusions: The presence of DR was associated with an increased risk of all-cause mortality and CV events in both type 2 and type 1 diabetic patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram shows the literature search to identify cohort studies that evaluated DR and all-cause mortality and/or CV events (fatal and nonfatal) of diabetic patients.
Figure 2
Figure 2
Meta-analyses of the association between presence of DR and (A) all-cause mortality and/or CV events (fatal and nonfatal) and (B) all-cause mortality in both type 2 and type 1 diabetic patients. (A high-quality color representation of this figure is available in the online issue.)
Figure 3
Figure 3
Bayes normogram for DR shows post-test probability of all-cause mortality and/or CV event in type 2 (A) and in type 1 (B) diabetic patients with DR (upper line) and without DR (lower line). C: Nomogram is shown for advanced DR in type 2 diabetic patients.
See this image and copyright information in PMC

References

    1. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010;304:649–656 - PMC - PubMed
    1. Fong DS, Aiello LP, Ferris FL, 3rd, Klein R. Diabetic retinopathy. Diabetes Care 2004;27:2540–2553 - PubMed
    1. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413–1418 - PubMed
    1. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 1999;117:1487–1495 - PubMed
    1. Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH, EURODIAB Prospective Complications Study Group Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 2008;31:1360–1366 - PMC - PubMed

Publication types

MeSH terms